Verified· 2 sources

HemostOD SA

Summary

About the company

The core activity of HemostOD is the development and manufacture of universal, genetically modified platelets (thrombocytes) for medical applications, including the treatment of thrombocytopenia, targeted delivery of active substances to specific tissues, and applications in regenerative medicine and the culture of therapeutic stem cells.

AI-generated

Offering

Products & services

Industry:Medical Technology Industry

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

HemostOD SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

HemostOD SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

HemostOD SA in comparison

Industry comparisons are coming soon

Similar companies